COVID-19 changing regulatory picture around medical devices and technology in healthcare

Truman Slate

Picture: Luis Alvarez/Getty Illustrations or photos

The COVID-19 pandemic has adjusted the regulatory photo around clinical units and know-how in health care, and the way in which all those systems are reimbursed. Consider telehealth, for instance, which has noticed higher reimbursement flexibility from the Centers for Medicare and Medicaid Companies.

Some of these changes have presented chances for business owners and item developers, and policymakers have taken take note and realized classes that may enable grease the wheels for potential item progress and the regulatory construction that surrounds them.

In broad strokes, this is the subject that will be protected in the HIMSS21 Digital session, “Regulations and Reimbursement: How to Navigate Compliance in an Uncertain Planet,” which premieres on Aug. 10. Speaking at the session are Amy Abernethy, previous principal deputy commissioner and acting chief information officer at the U.S. Foods and Drug Administration Deven McGraw, chief regulatory officer at

Read More